EngenderHealth Board of Directors Announces Interim President & CEO
December 1, 2017–The EngenderHealth Board of Directors has unanimously voted to appoint Rosemary Ellis, secretary of the Board, as Interim President and CEO of the organization, effective immediately.
Rob Petty, Chair of the Board, said, “We are honored that Rosemary has agreed to serve during this crucial time of transition for the organization. And we are very grateful to have her step into this role and provide us with strong and steady leadership during our continued strategic evolution.”
Ellis has served on the EngenderHealth Board for eight years, and has deep experience in executive management, strategic development, brand building, marketing, and media. She has long been involved in causes that protect and further the reproductive health and rights of women and girls.
A committee of the Board of Directors is launching a global search to recruit a permanent President and CEO. Ellis will serve as CEO until a permanent replacement has been identified, and she will temporarily step down from the Board of Directors while she holds this interim position.
She can be reached at firstname.lastname@example.org.
EngenderHealth is a leading global women’s health organization committed to working toward a world where sexual and reproductive rights are respected as human rights and women and girls have the freedom to reach their full potential. In nearly 20 countries around the world, EngenderHealth creates lasting change by training health care professionals and partnering with governments and communities to make high-quality family planning and sexual and reproductive health services available today and for all generations to come. Visit www.engenderhealth.org for more information.